-
Serum Institute obtains DCGI nod to produce Sputnik V vaccine in India
pharmaceutical-technology
June 08, 2021
The Drug Controller General of India (DCGI) has granted approval to the Serum Institute of India (SII) to produce Russia’s Covid-19 vaccine, Sputnik V, in the country.
-
Argentina Formally Starts Producing Russia’s Sputnik Covid-19 Vaccine
firstwordpharma
June 07, 2021
Argentina and Russia's president formally announced that a pharmaceutical company in the South American nation will start producing the Sputnik V COVID-19 vaccine, Bloomberg reported.
-
SII gets approval from DCGI to produce Sputnik V vaccine in India
expresspharma
June 07, 2021
The firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology for developing Sputnik V at its licensed Hadapsar facility.
-
Anvisa allows import of Covaxin, Sputnik V into Brazil, but conditions apply
expresspharma
June 07, 2021
According to Anvisa's approval, Brazil is expected to receive four million doses of Covaxin initially.
-
Malta-based company to provide up to 60 million doses of Sputnik V vaccine to Haryana
expresspharma
June 07, 2021
The firm has given a timeline of 30 days to supply the first batch of five lakh doses, followed by 10 lakh doses every 20 days till the supply is completed.
-
RDIF, UNICEF sign agreement for supply of 220 million doses of Sputnik V vaccine
expresspharma
May 31, 2021
Concurrently, RDIF will be holding a separate discussion with Gavi, the Vaccine Alliance to see the Sputnik V vaccine considered for inclusion in the COVAX Facility’s Portfolio of COVID-19 vaccines.
-
RDIF, Panacea Biotec launch production of Sputnik V in India
expresspharma
May 25, 2021
The Russian Direct Investment Fund (RDIF) and Panacea Biotec announced the launch of production of the Russian Sputnik V vaccine against coronavirus.
-
Dr Reddy’s, RDIF in discussions on production of Sputnik V for other countries
expresspharma
May 21, 2021
In addition, there are discussions with RDIF for Sputnik light, a single dose vaccine for COVID-19 being developed in Russia as well as additional engagement for the future for India, informed a senior official of Dr Reddy’s.
-
Shilpa Medicare partners with Dr Reddy’s for Sputnik V vaccine production
expresspharma
May 18, 2021
The companies are also exploring the option to manufacture Sputnik Light, a single-dose version of the vaccine in the near future.
-
Dr Reddy’s announce launch of Sputnik V vaccine in Indian market
expresspharma
May 17, 2021
Dr Reddy’s Laboratories announced that the first consignment of imported doses of the Sputnik V vaccine that landed in India on May 1, 2021, received regulatory clearance from the Central Drugs Laboratory, Kasauli, on May 13, 2021.